Screener

Gross Revenue From Contract With Customer Excluding Assessed Tax Before Amortization Of Capitalized Fees

Name: Innoviva, Inc. Gross Revenue From Contract With Customer Excluding Assessed Tax Before Amortization Of Capitalized Fees by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Innoviva, Inc.·Products & Services·3 segments

Breakdown

Segment	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Royalty	$60.51M	$65.98M	$61.26M	$67.34M	$63.35M	$58.35M	$58.62M	$59.79M
Long Acting Beta2Agonist Relvar Breo	$48.2M	$53.61M	$50.89M	$54.74M	$51.51M	$46.89M	$47.28M	$47.66M
Long Acting Beta2Agonist Anoro	$12.31M	$12.37M	$10.37M	$12.6M	$11.84M	$11.47M	$11.35M	$12.14M
Total	$48.2M	$53.61M	$50.89M	$54.74M	$51.51M	$46.89M	$47.28M	$47.66M

Segments

Long Acting Beta2Agonist Relvar BreoView metric

Long Acting Beta2Agonist AnoroView metric

RoyaltyView metric